Introduction

V
itamin D deficiency (VDD) is associated with reduced intestinal absorption of calcium, leading to low bone mineralisation (rickets and osteomalacia), skeletal deformities, hypocalcaemic seizures, tetany, and heart disease.
1,2 VDD can also manifest as musculoskeletal pain and weakness that may ultimately result in falls in the elderly population. 3 A recent post-mortem study conducted in Germany found that the prevalence of undiagnosed osteomalacia was as high as 25% in the adult population. 4 VDD affects populations worldwide and its prevention and improvement in nutritional status is a global public health priority, thereby ensuring optimal bone health in both children and adults. 1, 5 The main source of vitamin D is ultraviolet radiation (UV-B) containing sunlight, which prompts vitamin D production in the skin. VDD is therefore endemic in high latitude settings (>35 N) such as the UK, 5 Canada, 6 Belgium, 7 and Scandinavia 5 where less UV-B sunlight is obtained throughout the year. Despite this geographical fact, VDD has predominantly been reported in low-and mid-latitudes (0 -35 ), namely African and Asian countries, where cultural and dietary factors limit sunlight exposure and calcium intake. 8 Vitamin D from sunlight or food sources is biologically inactive and needs to be converted in the human body, via two hydroxylation steps, into the hormone calcitriol (also called active vitamin D) whose function is to maintain healthy levels of calcium and phosphorus by increasing the intestinal absorption of those bone minerals. 1 Therefore, vitamin D is an indirect determinant of bone mineralization during childhood and adulthood. The best measure of vitamin D status is the also biologically inert 25 hydroxyvitamin D (25OHD), present in the blood serum. The main risk factors for VDD include older age, dark skin pigmentation, and any barrier to UV-B light reaching the skin such as full body clothing, spending most time indoors, and air pollution. 8 Because vitamin D is fundamental for healthy bone development and growth, optimal vitamin D intake is crucial in infants and young children, as well as pregnant and breastfeeding women. Therefore, these populations are a common public health target, with the aim of avoiding irreversible consequences of severe VDD. 9 Most countries have adopted public health policies to prevent VDD in at-risk groups of the population, 10 opting for either (i) mandatory fortification of staple foods such as milk (Sweden and Finland) or voluntary fortification of, for example, breakfast cereals (UK), 10 or (ii) supplementation programmes for pregnant and breastfeeding women, and infants. 10 Despite these initiatives, VDD still persists as a serious public health concern. 5 A recent study conducted in Europe pooled estimates from 55 844 individuals and found that VDD, defined as serum 25OHD concentrations below 30 nmol l À1 , affects 13% of the European population. 5 The evidence is robust about the much higher prevalence of VDD in dark-skinned populations, highlighting the inadequacy of the current policies in Europe to protect the at-risk groups. 2, 5, 11 There has been continued research effort to determine a population strategy that is both clinically-and cost-effective. In November 2014, the UK's National Institute for Health and Care Excellence identified a lack of economic evidence to support vitamin D supplementation for certain groups of the population. 12 In addition, in 2016, the global consensus recommendations on the prevention and management of rickets highlighted the paucity of economic evaluation of rickets prevention strategies. 8 This study aims to systematically review economic evaluations of VDD prevention and identify the evidence gaps to inform future research and public health policy.
In addition, it aims to:
Determine the cost-effectiveness of population strategies. Identify whether cost-effectiveness varies by population subgroup and country setting. Identify and appraise alternative modelling structures for measuring the cost-effectiveness of population strategies. Determine the methods used for measuring the outcomes of strategies to prevent VDD (for example, death, quality-of-life, fractures, falls).
Methods
Search strategy
This review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement, 13 where applicable. PRISMA provides reporting guidance through a 27-item checklist and a flow diagram, with the aim of improving the quality and transparency of systematic reviews and meta-analyses. 13 Literature searches were conducted in January 2015 and updated in April 2016. The search strategy included terms relating to VDD and health economics (full search strategy provided in the Supplementary data). The following bibliographic databases were searched: MEDLINE, EMBASE, Econlit, NHS EED, CEA, and RepEC. Additionally, the reference lists of the included articles were searched. The screening was conducted by the main reviewer (M.A.) and the second reviewer (E.F.) screened 10% of the titles and abstracts.
Inclusion/exclusion criteria
All full economic evaluations, defined as a consideration of both costs and outcomes together, were included namely cost-consequence, cost-effectiveness, cost-utility, and cost-benefit analyses. The interventions of interest were those aiming to prevent VDD, including supplementation, food fortification, and public health campaigns. Interventions were included if administering vitamin D alone, vitamin D in combination with calcium or multi-vitamin supplements containing vitamin D. There were no language restrictions. Studies where VDD occurred as secondary to other health conditions, such as liver disease or malabsorption, were excluded.
Data extraction
The relevant characteristics of each study in relation to the methods used and main results were extracted. The data extracted included: population, setting, intervention and comparators, type of economic evaluation, analytical methods used, the perspective adopted, clinical outcomes and measures of benefits used, and the main results reported.
Drummond's checklist 14 was chosen to assess the quality of the included studies because it is a widely used quality tool that allows assessment of different types of economic evaluations including costeffectiveness, cost-utility, and cost-benefit analysis, as well as any analytic method-model-based and trial-based analysis -allowing us to use the same tool for all included studies and directly compare their quality. Studies were not excluded from the analysis on the basis of the quality assessment results, rather, the quality of the studies was considered when drawing conclusions from the synthesised data.
Data synthesis
Firstly, the results were categorised by type of prevention strategy being evaluated. Secondly, the studies were grouped by type of intervention analysed. High heterogeneity was expected across studies due to the great variation in costs and resources used both between countries and within the same country. Therefore, pooled estimates were not considered appropriate to summarise the evidence.
Results
Our search strategy generated 2492 references after duplicates were removed. All titles and abstracts were checked against the inclusion/ exclusion criteria. Studies that were not economic evaluations, and/ or did not evaluate strategies to prevent VDD were excluded. As a result, 2466 were excluded and the primary reason for exclusion was not being a full economic evaluation. The remaining 26 full-text studies were examined and 14 studies were selected for data extraction, 9 from the main search, and 5 from the updated searches. A flowchart illustrating the study selection process is shown in figure 1 , including the reasons for excluding at full-text screening stage.
General characteristics of the included studies
The identified studies spanned a period of 20 years, with the earliest being published in 1995 and the majority emerging between 2012 and 2016. Studies were carried out in the UK, [15] [16] [17] [18] [19] the USA, 20, 21 Australia, 22, 23 France, 24 Finland, 25 Sweden, 26 and Germany. 27 Additionally, there was one multi-country study that carried out cost-effectiveness analyses in seven European countries 28 (table 1) .
The majority of studies (n = 7) evaluated supplementation strategies of vitamin D alone in the adult population. 16, 17, 20, 21, [23] [24] [25] Other studies investigated calcium and vitamin D interventions either through oral supplements (n = 4) 15, 22, 26, 28 or food fortification (n = 1). 27 One study evaluated interventions of supplementation with multi-vitamins that included vitamin D. 19 The general characteristics of the included studies evaluating supplementation strategies are presented in table 1; and table 2 
Supplementation with vitamin D alone
Eight studies evaluated interventions using supplements with vitamin D alone [16] [17] [18] [20] [21] [22] 24, 25 and all except one 18 focused on the elderly population (table 1) . Five were cost-utility analyses using qualityadjusted life-years (QALYs) to measure benefits, 16, 20, 21, 23, 24 two were cost-effectiveness analyses 17, 25 and one was a cost-consequence analysis. 18 Three studies compared universal supplementation against screening for VDD followed by supplementation, 18, 21, 24 three studies evaluated vitamin supplements against interventions to prevent falls 20, 23, 25 and two evaluated supplements against current care to prevent fractures 17 and falls. 16 Markov models were the preferred analytical method to simulate falls and fractures pathways (n = 4). 16, 17, 21, 23 Screening and subsequent treatment was found to be more cost-effective than universal supplementation in the elderly population, 21, 24 while universal supplementation was cost-saving when comparing to the screening alternative in the whole population. 18 Interventions with vitamin D supplements in the elderly population were cost-effective when compared with current practice for the prevention of falls 16 and fractures 17 , and when compared with multiple interventions for the prevention of falls. 20, 23 Supplementation with vitamin D and calcium Four economic evaluations focused on the prevention of VDD using supplements with a combination of vitamin D and calcium (table 1) . 15, 22, 26, 28 Two of them were cost-utility analyses using QALYs as a measure of benefit 22, 26 and two were cost-effectiveness analyses measuring the cost per 'avoided fracture'. 15, 28 Three studies 15, 26, 28 sourced the effectiveness data from a large French trial 29, 30 involving women in nursing homes. Two of these performed a trial-based analysis 15, 28 while another modelled the outcomes beyond the trial follow-up period through a Markov model. 26 When compared with placebo, vitamin D and calcium were cost-effective in women aged 50 and 60 years 26 and costsaving for at-risk women aged over 70-years-old in Sweden 26 and several other European countries. 28 When compared with annual supplementation of high-dose vitamin D only [300 000 international units (IU)], the latter was found to be more cost-effective. 15 A different approach was used by Church et al., 22 who aimed to identify the most cost-effective intervention to prevent falls by comparing multiple interventions, including vitamin D and calcium supplementation, as well as Tai-chi, medication reviews and multi-factorial approaches. Two different Markov models were used for the elderly population living in the community and in residential aged care homes. Combined supplementation of vitamin D and calcium was one of the most cost-effective interventions for those living in residential aged care facilities (ICER AU$7316), but not for those living in the community. Records screened (n =2492)
Records excluded (n =2466)
Full-text arƟcles assessed for eligibility (n =26)
Full-text arƟcles excluded, with reasons (n =12)
AddiƟonal records idenƟfied through other sources (n =3)
AddiƟonal records idenƟfied through updated searches (n =217) Figure 1 Systematic literature selection flowchart 
Supplementation with multi-vitamin preparation containing vitamin D
One study evaluated an intervention using multi-vitamin supplements containing vitamin D (table 1) . 19 Different schemes of universal and targeted supplementation strategies were compared and the effectiveness and outcomes measures were not limited to vitamin D but included folic acid and vitamin C for pregnant and breastfeeding women, and vitamin A and C for infants and young children. 19 The results were largely driven by the effect of folic acid in pregnant women, due to the lack of effectiveness data for the other micronutrients, including vitamin D.
Food fortification with vitamin D and calcium
One study evaluated food fortification with vitamin D and calcium to prevent fractures in elderly women in Germany (table 2) . 27 It was a cost-effectiveness analysis comparing no fortification, which is the current German policy, with voluntary bread fortification. The analysis used a fortification model based on the German population's bread consumption. 31 Effectiveness data on the fracture risk reduction was based on a Cochrane review of the effectiveness of vitamin D and calcium supplements. 32 The authors found the intervention was cost-saving. 27 
Quality assessment
All papers reported the type of economic evaluation, described the alternatives being analysed and adequately drew conclusions from the results, although none of the studies fulfilled all the checklist's requirements (full results provided in Supplementary data). There was a general lack of rigour in reporting the methods, and the model inputs and assumptions. Most studies failed to provide justification for key methodological choices such as the time horizon, the analytical approach and the discount rates chosen. There was also limited discussion about the sources of effectiveness data and how these affected the generalizability of the results.
Discussion
This systematic review provides the first synthesis of the economic evidence on the prevention of population VDD. The review demonstrates that economic evaluation of interventions to prevent VDD is an expanding area of research, with 5 of the 14 included studies being published in 2015. Despite the increasing number of studies, the evidence is still limited and does not address the main questions important to policy makers when considering the introduction of VDD prevention strategies. From the literature, it is not possible to determine the total costs of population strategies, nor the most costeffective population strategy to prevent VDD and its consequences. Vitamin D is a relatively inexpensive compound and the literature shows that it is potentially cost-effective, particularly when used to prevent clinical outcomes with high burden such as fractures in the elderly population (table 3) . Therefore, the effectiveness of vitamin D and the incidence of falls and related fractures were important drivers of the results. We highlight below the main strengths and limitations of the currently available evidence and provide recommendations for future research. A summary of the studies' results and scope is presented in table 3.
Population
The majority of the economic evaluations focused on the elderly population (table 3) living in Western countries, highlighting a dearth of studies in all other at-risk groups: infants and children, pregnant women, lactating women and ethnic minorities, as well as populations living in other geographical areas, in particular those with high prevalence of rickets.
Severe symptomatic VDD has been reported in dark skinned infants, namely rickets, cardiomyopathy, and seizures. 2, 9 This review found only one study which attempted a sub-group analysis focusing on dark skinned adult populations but results were limited by the paucity of evidence to support the analysis. 18 Despite this, the study showed that, when the incidence of VDD increased, so did the probability of supplementation being costeffective for that population. 18 This suggests that interventions that are not cost-effective for the whole population may be costeffective for at-risk groups, reinforcing the need for sub-group analysis by risk. For example, cost-effectiveness is likely to be greater in strategies targeted to the groups at higher risk of rickets and osteomalacia, as it is the case of dark skinned populations.
Type of economic evaluation and analytic approaches
The majority of the studies performed cost-effectiveness (n = 6) and cost-utility (n = 7) analyses, with a focus on health and social care costs and outcomes. The holistic nature of population-based nutrition interventions, which can lead to non-health care costs and benefits suggests that an alternative method of economic evaluation such as cost-benefit analysis may be more appropriate. This is important as the costs of nutrition interventions are likely to involve public health authorities and other public sectors, food consumers and the food industry. At the same time, the health benefits of population nutrition interventions can be far reaching, for instance, better childhood development will improve productivity in later years.
Regarding the analytical methods used, six studies presented decision models, all Markov models, simulating the prevention of fractures 17, 26 or falls. 16, [21] [22] [23] Markov models are appropriate as they enable long-term programmes to be modelled and account for recurrence. VDD and its complications are dynamic health states, where patients transit from being deficient to being sufficient (i.e. seasonally). This transition is determined by exposure to risk factors, including sunlight exposure, age, and vitamin D and calcium intake from food and supplements, which vary with time and external factors.
Interventions
Thirteen of the 14 included studies evaluated supplements with vitamin D, and different supplementation programmes were considered, all in the elderly (table 3). The majority of the studies 24 The comparators varied and included exercise, 25 screening followed by treatment, 18, 21, 24 multi-interventions to prevent falls, 20, 22, 23 parenteral vitamin D supplementation 15 and no intervention. 16, 17, 26, 28 Only one study evaluated food fortification. 27 Most of the interventions compared targeted a specific group of the population and aimed to prevent one clinical outcome related to VDD. The results are therefore unlikely to apply to population-based scenarios. For instance, two studies evaluating screening programmes vs. supplementation in older adults concluded that screening would be more cost-effective than providing supplements, particularly to those aged over 70 years and those at high-risk of fractures. 21, 24 But the one study comparing the same intervention in the whole population found contrasting results, concluding that it is unlikely that universal vitamin D screening would be superior to universal supplementation at population level. 18 There is a lack of studies evaluating population-based programmes. The only two studies that undertook broader analyses in several at-risks groups in the UK's population 18, 19 highlight serious limitations due to the evidence gaps to support such analyses.
Considering the low uptake of vitamin D supplements 37 and the heterogeneity in food consumption among different population groups, the preferred public health approach to improve the nutritional vitamin D status of the whole population is likely to be a combination of food fortification and supplementation policies. Similar conclusions have been drawn for other micronutrients. 33, 34 Nonetheless, economic evaluations of combined interventions to prevent VDD have not yet been undertaken. We reiterate that stand-alone interventions may not be the most efficient strategy and highlight the importance of producing new economic evidence evaluating multi-interventions.
Clinical outcomes
The most used clinical outcomes were fractures (n = 8) 15, 17, 18, 20, 24, [26] [27] [28] and falls (n = 5), 16, [21] [22] [23] 25 although the evidence supporting such associations is controversial. The latest Cochrane reviews suggested that supplementation with vitamin D alone has no impact on risk of fractures 32 but may reduce the risk of falls in individuals with low vitamin D status at baseline, if a minimum of 800 IU per day is provided. 35 The association of Vitamin D and calcium is likely to prevent a small number of hip and non-vertebral fractures in the elderly population. 32 The choice of clinical outcome and the source of effectiveness data must be carefully considered and estimates tested in sensitivity analysis. For example, hip fractures have a great impact on morbidity, quality of life and mortality. They are also one of the costliest health outcomes in the elderly population. Therefore, risk reduction of hip fractures is likely to drive cost-effectiveness results. 27 VDD has severe clinical consequences in children, namely rickets, which is associated with pain, bone deformities, muscle weakness, poor growth, hypocalcaemic seizures, tetany, and heart disease and their sequelae, including death. 8 Despite their high prevalence in risk groups, 11 these outcomes have not yet been picked up by health economics research.
Effectiveness
The effectiveness of supplementation programmes was largely sourced from clinical trials and meta-analyses of clinical trials. Because clinical trials are conducted in controlled environments and generally have a short-time frame, the recorded uptake rates are expected to be higher than those observed in real-life conditions. The World Health Organization (WHO) states that Much lower rates, as low as 6%, were reported for the vitamin D supplements provided under the free supplementation scheme for infants in the UK. 37 Therefore, economic evaluations assuming 100% uptake rate will overestimate the benefits of supplementation programmes. Furthermore, we found that pooled estimates of the effect of vitamin D supplementation frequently included data from trials using vitamin D alone and vitamin D in combination with calcium, 16, 17 making it impossible to determine how much of the effect is attributable to vitamin D alone.
The effectiveness of food fortification with vitamin D is an underresearched area and this may explain the paucity of economic evaluations of these strategies. The one study evaluating fortification programmes sourced its effectiveness data of vitamin D and calcium from a Cochrane review using supplements. 27 Several important parameters must be taken into account when considering the effectiveness and coverage of food fortification, such as the characteristics of the food vehicle and its bio-availability. The food vehicle needs to be accessible, ideally a staple food with a well-established consumption pattern within the targeted population. 33 Moreover, chemical characteristics of both the nutrient and the food need to be considered to guarantee that the nutrient will be delivered in the desired amounts after food processing, package, and storage.
Utilities
The QALYs gained from the prevention of VDD were used in eight of the fourteen included studies. 16, [19] [20] [21] [22] [23] [24] 26 Utility measures were sourced from osteoporosis studies and used in economic evaluations of preventing falls 16, [21] [22] [23] and fractures. 20, 24, 26 In studies focusing on falls prevention, fear of falling after a fall was an important cause of QALY decrement, in some cases having more impact on the quality of life of those who suffered a fall than fractures. 38 Although attempts have been made to include QALY estimates for pregnant women and children, 12 the authors were limited by the complete lack of evidence on the disutility of being vitamin D deficient beyond the falls and fractures related outcomes.
Costs and resources used
The current literature is relatively homogenous in the methods used to cost programmes and how costs and resources used are reported. The studies focused on the healthcare sector, with great emphasis being given to the cost of purchasing vitamin D, either as a supplement or as a fortificant, and to treating clinical events related to VDD. However, micronutrient interventions are complex and their costs span across several public and private sectors. The current literature still treats these interventions as exclusively health programmes, providing limited information for policy makers.
Previous research on vitamin A programmes showed that the main driver of the overall cost of the programme was staff costs in supplementation and the nutrient's cost in food fortification programmes. 33 Moreover, it highlighted the importance of accounting for information campaigns and staff training, without which the effectiveness of the programmes is compromised.
Quality of the studies
In general, studies adequately describe interventions compared, the outcome measures and satisfactory drew conclusions from the results reported. Nonetheless, the quality assessment highlighted poor reporting practices namely the lack of justification of the type of economic evaluation used, the choice of perspective and alternatives compared. Full results are presented in Supplementary data and summarised in table 3. It is possible that, because studies have been published in clinical journals, the authors have chosen to emphasise clinical aspects in detriment of analytical methods.
Recommendations for future research
We highlight the following recommendations for researchers planning economic evaluations of population strategies to prevent VDD:
VDD affects all age groups and new economic evaluations should consider the impact of VDD in children, as well as in adults. Exclusion of groups of the population should be justified. Groups at high-risk for VDD and its most severe symptoms should be considered in sub-group analysis. It is likely that interventions that improve the VD status in these populations will have greater cost-effectiveness. We recommend that a societal perspective is considered, given the holistic nature of VDD and public health strategies to prevent it. VDD can be prevented through both supplementation and food fortification and most countries have implemented a combination of both. Economic evaluations of combined strategies are needed to support policy-making. A broad cost analysis is recommended, considering the costs incurred by the health sector on national and local authorities' level, the food industry and other private entities, and the consumers. Effectiveness of vitamin D preventive strategies is complex. In the case of supplementation, uptake rates have a great impact on the cost-effectiveness of the interventions and a range of values should be modelled. For food fortification programmes, there is limited research on the effectiveness of population strategies and comprehensive uncertainty analysis should be carried out.
Conclusion
Interventions to prevent VDD have been referred to in the literature as highly cost-effective and even cost-saving for some groups of the population. Nonetheless, the evidence shows several limitations that need to be addressed for a better understanding of what would be the most cost-effective approach to prevent VDD at a population level. This review found a lack of economic evaluations supporting population VDD prevention, and corroborates previous concerns about the underuse of economic evaluation to inform public health nutrition strategies. 39, 40 Micronutrient deficiencies are effectively prevented through supplementation and food fortification programmes and most countries have adopted a combination of both. 33 None of the studies included in this review presented a direct comparison of the two strategies, neither considered a combined intervention of food fortification and supplementation. Therefore, it is not possible to conclude which intervention is the most cost-effective. The literature suggests that supplementation with 800 IU of vitamin D is likely to be costeffective to prevent fractures and falls in older adults, especially for the elderly, high-risk population. Economic evaluations focusing on population-based interventions are needed, as well as sub-group analysis of other at-risk group such as infants, children, breastfeeding and pregnant women and individuals with darker skin.
The literature on micronutrient programmes refers to food fortification as a highly cost-effective alternative to tackle deficiencies for its wide population coverage and low maintenance costs. 33 Further research is needed to evaluate if the same applies to vitamin D interventions.
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